FDA: Public-Private Venture Set to Improve Regulatory Science

Medical Device Innovation Consortium will collaborate with FDA to better evaluate new devices

THURSDAY, Dec. 6 (HealthDay News) -- The Medical Device Innovation Consortium (MDIC), the first public-private partnership to promote medical device regulatory science, has been established, according to a Dec. 3 news release issued by the U.S. Food and Drug Administration.

The MDIC, an independent nonprofit corporation created by LifeScience Alley, a biomedical trade association, will collaborate with FDA staff and receive input from industry, government, and other nonprofit organizations. The consortium aims to promote medical device regulatory science by simplifying both the process of medical device design and the pathways to market these innovations.

According to the report, the MDIC will prioritize the regulatory science needs of the medical device community, including those involved in developing new tools, standards, and approaches to evaluate the safety, efficacy, quality, and performance of FDA-regulated products. To better assess new devices, the MDIC will pool people, resources, funding, and ideas. The consortium will focus on speeding the development, evaluation, and review of new medical devices with the goal of improving the process involved and reducing the time and costs related to getting the product to market.

"By sharing and leveraging resources, MDIC may help industry to be better equipped to bring safe and effective medical devices to market more quickly and at a lower cost," Jeffrey Shuren, M.D., J.D., director of the FDA's Center for Devices and Radiological Health, said in a statement.

More Information

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95

Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95

Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95

More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events